New hope for ovarian cancer: drug combo aims to extend remission
NCT ID NCT07225270
First seen Nov 06, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study tests whether adding the experimental drug Rina-S to standard therapy helps keep ovarian cancer from growing back in people whose cancer had previously responded to platinum chemotherapy. About 528 adults with recurrent platinum-sensitive ovarian cancer will receive either Rina-S alone, Rina-S plus bevacizumab, bevacizumab alone, or monitoring only. The goal is to see if the combination delays cancer progression and improves survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hyogo Cancer Center
RECRUITINGAkashi, Hyōgo, Japan
-
Miami Valley Hospital South
RECRUITINGCenterville, Ohio, 45459, United States
-
Mie University Graduate School Of Medicine
RECRUITINGTsu, Mie-ken, Japan
-
Mt. Sinai Comprehensive Cancer Center
RECRUITINGMiami, Florida, 33140, United States
-
National Hospital Organization Hokkaido Cancer Center
RECRUITINGSapporo, Hokkaido, Japan
-
Niigata University Medical & Dental Hospital
RECRUITINGNiigata, Japan
-
Osaka Medical and Pharmaceutical University Hospital
RECRUITINGTakatsuki, Osaka, Japan
-
Saitama Medical University International Medical Center
RECRUITINGHidaka, Saitama, Japan
-
Sapporo Medical University Hospital
RECRUITINGSapporo, Hokkaido, Japan
-
The Cancer Institute Hospital of JFCR
RECRUITINGTokyo, Japan
Conditions
Explore the condition pages connected to this study.